Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Roland Wolf

Showing results (141-150 of 159) with videos related to

Pageof 16
Sort By:
Carcinogenesis|January 22, 2008
Metabolic activation of benzo[a]pyrene in vitro by hepatic cytochrome P450 contrasts with detoxification in vivo: experiments with hepatic cytochrome P450 reductase null miceVolker M Arlt, Marie Stiborová, Colin J Henderson, et al.
The Biochemical Journal|May 7, 2002
Loss of the Nrf2 transcription factor causes a marked reduction in constitutive and inducible expression of the glutathione S-transferase Gsta1, Gsta2, Gstm1, Gstm2, Gstm3 and Gstm4 genes in the livers of male and female miceSimon A Chanas, Qing Jiang, Michael McMahon, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 23, 2012
NADPH-cytochrome P450 oxidoreductase: roles in physiology, pharmacology, and toxicologyDavid S Riddick, Xinxin Ding, C Roland Wolf, et al.
Archives of Toxicology|March 5, 2025
The potent human CAR activator CITCO is a non-genotoxic hepatic tumour-promoting agent in humanised constitutive androstane receptor mice but not in wild-type animalsC J Henderson, A W McLaren, A K MacLeod, et al.
Archives of Toxicology|June 26, 2026
Correction: The potent human CAR activator CITCO is a non-genotoxic hepatic tumour-promoting agent in humanised constitutive androstane receptor mice but not in wild-type animalsC J Henderson, A W McLaren, A K MacLeod, et al.
Plos One|October 25, 2011
Humanizing π-class glutathione S-transferase regulation in a mouse model alters liver toxicity in response to acetaminophen overdoseMatthew P Vaughn, Debika Biswal Shinohara, Nicole Castagna, et al.
Life Science Alliance|October 17, 2019
Drug-induced chromatin accessibility changes associate with sensitivity to liver tumor promotionAntonio Vitobello, Juliane Perner, Johanna Beil, et al.
Pharmacogenetics and Genomics|June 19, 2009
Nomenclature for alleles of the cytochrome P450 oxidoreductase geneSarah C Sim, Walter L Miller, Xiao-Bo Zhong, et al.
Cancer Research|May 20, 2016
Loss of Tet1-Associated 5-Hydroxymethylcytosine Is Concomitant with Aberrant Promoter Hypermethylation in Liver CancerJohn P Thomson, Raffaele Ottaviano, Elif B Unterberger, et al.
British Journal of Cancer|July 4, 2025
AKT/mTOR as a targetable hub to overcome multimodal resistance to EGFR inhibitors in oesophageal squamous cell carcinomaLindsay C Spender, Dale M Watt, Mark A Baxter, et al.
Pageof 16

Showing results (141-150 of 159) with videos related to

Sort By:
Pageof 16
Carcinogenesis|January 22, 2008
Metabolic activation of benzo[a]pyrene in vitro by hepatic cytochrome P450 contrasts with detoxification in vivo: experiments with hepatic cytochrome P450 reductase null miceVolker M Arlt, Marie Stiborová, Colin J Henderson, et al.
The Biochemical Journal|May 7, 2002
Loss of the Nrf2 transcription factor causes a marked reduction in constitutive and inducible expression of the glutathione S-transferase Gsta1, Gsta2, Gstm1, Gstm2, Gstm3 and Gstm4 genes in the livers of male and female miceSimon A Chanas, Qing Jiang, Michael McMahon, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 23, 2012
NADPH-cytochrome P450 oxidoreductase: roles in physiology, pharmacology, and toxicologyDavid S Riddick, Xinxin Ding, C Roland Wolf, et al.
Archives of Toxicology|March 5, 2025
The potent human CAR activator CITCO is a non-genotoxic hepatic tumour-promoting agent in humanised constitutive androstane receptor mice but not in wild-type animalsC J Henderson, A W McLaren, A K MacLeod, et al.
Archives of Toxicology|June 26, 2026
Correction: The potent human CAR activator CITCO is a non-genotoxic hepatic tumour-promoting agent in humanised constitutive androstane receptor mice but not in wild-type animalsC J Henderson, A W McLaren, A K MacLeod, et al.
Plos One|October 25, 2011
Humanizing π-class glutathione S-transferase regulation in a mouse model alters liver toxicity in response to acetaminophen overdoseMatthew P Vaughn, Debika Biswal Shinohara, Nicole Castagna, et al.
Life Science Alliance|October 17, 2019
Drug-induced chromatin accessibility changes associate with sensitivity to liver tumor promotionAntonio Vitobello, Juliane Perner, Johanna Beil, et al.
Pharmacogenetics and Genomics|June 19, 2009
Nomenclature for alleles of the cytochrome P450 oxidoreductase geneSarah C Sim, Walter L Miller, Xiao-Bo Zhong, et al.
Cancer Research|May 20, 2016
Loss of Tet1-Associated 5-Hydroxymethylcytosine Is Concomitant with Aberrant Promoter Hypermethylation in Liver CancerJohn P Thomson, Raffaele Ottaviano, Elif B Unterberger, et al.
British Journal of Cancer|July 4, 2025
AKT/mTOR as a targetable hub to overcome multimodal resistance to EGFR inhibitors in oesophageal squamous cell carcinomaLindsay C Spender, Dale M Watt, Mark A Baxter, et al.
Pageof 16